Skip to main content
Premium Trial:

Request an Annual Quote

Wyeth Takes License to Ingenuity Pathway Analysis Application

NEW YORK, Jan. 26 (GenomeWeb News) - Ingenuity Systems said today that Wyeth has licensed its Ingenuity Pathways Analysis system.

 

The application allows researchers to generate biological networks from gene or protein datasets.

 

Ingenuity, based in Mountain View, Calif., recently licensed the application to SurroMed, the Genomics Institute of the Novartis Research Foundation, the Stanford Genome Technology Center, and GlaxoSmithKline.

 

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.